Back to Search
THOMAS GUILLOT, M.D.
M.D.
Specialist
NPI: 1336147925Individual
Specialties, Licenses & Credentials
Research & Publications (14)
Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.
PMID 19259829·Mol Neurobiol·2009
6-review
Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis.
PMID 18980909·J Mot Behav·2008
7-preclinical
Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis.
PMID 18643795·J Neurochem·2008
7-preclinical
PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity.
PMID 18533255·Neuropeptides·2008
7-preclinical
An evaluation of mesotherapy solutions for inducing lipolysis and treating cellulite.
PMID 17954040·J Plast Reconstr Aesthet Surg·2008
8-other
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration.
PMID 17652604·J Neurosci·2007
4-observational
Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system.
PMID 17291500·Exp Neurol·2007
7-preclinical
Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
PMID 17038483·Toxicol Sci·2007
7-preclinical
Polychlorinated biphenyl-induced reduction of dopamine transporter expression as a precursor to Parkinson's disease-associated dopamine toxicity.
PMID 16702228·Toxicol Sci·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11914 ASTORIA BLVD, SUITE 470
HOUSTON, TX 77089 - Phone
- (281) 484-0088
Quick Facts
- NPI
- 1336147925
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile